Food allergy: how expensive are they?

PURPOSE OF REVIEW Food allergy remains a disease of global public health significance well known to impact social, emotional, and financial well being. This review aims to summarize the existing literature focused on the direct, indirect, and intangible costs of food allergy at the household and healthcare system levels, and begin to discuss how emerging treatment and prevention strategies may be leveraged to comprehensively care for the food allergic population with the efficient use of health resources. RECENT FINDINGS Food allergy imposes significant costs to multiple stakeholders and largely impact families at the household level. Recent studies elucidate the need to balance the household management of food allergy with the efficient use of health resources. Overall, it remains critical that safe foods and medications remain affordable while further exploring the cost-effectiveness of early introduction, emerging food allergy therapies, and the wider use of stock epinephrine to adequately meet the public health needs of the food-allergic community. SUMMARY Better understanding how the cost of food allergy impacts populations will help to inform more progressive policies aimed at lessening socioeconomic disparities and ultimately improve quality of life for children and adults with food allergies.

[1]  D. Golden,et al.  Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis , 2019, JAMA network open.

[2]  M. Greenhawt,et al.  Review Article: Providing Cost-effective Care for Food Allergy. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[3]  M. Greenhawt,et al.  CME Review Article: A Primer on Cost-effectiveness in the Allergy Clinic. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  M. Greenhawt,et al.  Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products , 2019, JAMA network open.

[5]  L. O’Dwyer,et al.  Economic burden of food allergy: A systematic review. , 2019, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  M. Greenhawt,et al.  Analysis of Value-Based Costs of Undesignated School Stock Epinephrine Policies for Peanut Anaphylaxis , 2019, JAMA pediatrics.

[7]  K. Nadeau,et al.  Prevalence and Severity of Food Allergies Among US Adults , 2019, JAMA network open.

[8]  William H. Yang,et al.  AR101 Oral Immunotherapy for Peanut Allergy , 2018, The New England journal of medicine.

[9]  K. Nadeau,et al.  The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States , 2018, Pediatrics.

[10]  D. Fleischer,et al.  “To screen or not to screen”: Comparing the health and economic benefits of early peanut introduction strategies in five countries , 2018, Allergy.

[11]  R. Lockey,et al.  Economic considerations in the treatment of systemic allergic reactions , 2018, Journal of asthma and allergy.

[12]  A. Sheikh,et al.  Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview , 2018, Allergy.

[13]  William H. Yang,et al.  Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial , 2017, JAMA.

[14]  M. Shaker An Economic Analysis of a Peanut Oral Immunotherapy Study in Children. , 2017, The journal of allergy and clinical immunology. In practice.

[15]  M. Shaker,et al.  Economic evaluation of epinephrine auto-injectors for peanut allergy. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[16]  L. Herbert,et al.  The emotional, social, and financial burden of food allergies on children and their families. , 2017, Allergy and asthma proceedings.

[17]  M. Wickman,et al.  Food-Related Symptoms and Food Allergy in Swedish Children from Early Life to Adolescence , 2016, PloS one.

[18]  G. Dimitriou,et al.  Cesarean section delivery and development of food allergy and atopic dermatitis in early childhood , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[19]  M. Greenhawt,et al.  The economic effect and outcome of delaying oral food challenges. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[20]  Ruchi S. Gupta,et al.  Quality of Life Among Food Allergic Patients and Their Caregivers , 2016, Current Allergy and Asthma Reports.

[21]  T. Conner,et al.  The stress of food allergy issues in daily life , 2016, Psychology & health.

[22]  Ruchi S. Gupta,et al.  Socioeconomic Disparities in the Economic Impact of Childhood Food Allergy , 2016, Pediatrics.

[23]  Xiaobin Wang,et al.  Differences in empowerment and quality of life among parents of children with food allergy. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  Jude T. Fleming,et al.  Early treatment of food-induced anaphylaxis with epinephrine is associated with a lower risk of hospitalization. , 2015, The journal of allergy and clinical immunology. In practice.

[25]  S. Dahlén,et al.  Household costs associated with objectively diagnosed allergy to staple foods in children and adolescents. , 2015, The journal of allergy and clinical immunology. In practice.

[26]  S. Dahlén,et al.  Socioeconomic evaluation of well‐characterized allergy to staple foods in adults , 2014, Allergy.

[27]  M. Mugford,et al.  The impact of double-blind placebo- controlled food challenge (DBPCFC) on the socioeconomic cost of food allergy in Europe. , 2014, Journal of investigational allergology & clinical immunology.

[28]  Ruchi Gupta,et al.  The economic impact of childhood food allergy in the United States. , 2013, JAMA pediatrics.

[29]  G. Roberts,et al.  Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study. , 2013, The Journal of allergy and clinical immunology.

[30]  K. Laitinen,et al.  Costs of allergic diseases from birth to two years in Finland. , 2012, Public health.

[31]  S. Alanne Nutrition economic evaluation of allergy treatment in infants and children: background for probiotic studies , 2012, Microbial ecology in health and disease.

[32]  David A Holdford,et al.  Estimating the economic burden of food-induced allergic reactions and anaphylaxis in the United States. , 2011, The Journal of allergy and clinical immunology.

[33]  M. Mugford,et al.  Household costs associated with food allergy: an exploratory study , 2010 .

[34]  C. Camargo,et al.  Socio‐economic status, geographic remoteness and childhood food allergy and anaphylaxis in Australia , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[35]  M. Mugford,et al.  Social and economic costs of food allergies in Europe: development of a questionnaire to measure costs and health utility. , 2009, Health services research.

[36]  J. Voordouw,et al.  Food allergic consumers' preferences for labelling practices: a qualitative study in a real shopping environment , 2009 .

[37]  R W R Crevel,et al.  The prevalence, cost and basis of food allergy across Europe , 2007, Allergy.

[38]  L. Frewer,et al.  Incorporating a gender dimension in food allergy research: a review , 2006, Allergy.

[39]  M. Mugford Economic impact of allergy prevention , 2005 .

[40]  M. Mugford,et al.  A framework for measuring costs to society of IgE‐mediated food allergy , 2005, Allergy.

[41]  H. Grandjean,et al.  Prevalence and main characteristics of schoolchildren diagnosed withfood allergies in France , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  H. Wichmann,et al.  Alternative medicine in allergies – prevalence, patterns of use, and costs , 2002, Allergy.